company background image
NIOX logo

NIOX Group AIM:NIOX Stock Report

Last Price

UK£0.64

Market Cap

UK£270.5m

7D

0%

1Y

37.6%

Updated

28 Mar, 2024

Data

Company Financials +

NIOX Stock Overview

NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide.

NIOX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends2/6

NIOX Group Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NIOX Group
Historical stock prices
Current Share PriceUK£0.64
52 Week HighUK£0.75
52 Week LowUK£0.42
Beta0.94
1 Month Change1.59%
3 Month Change-4.48%
1 Year Change37.63%
3 Year Change113.33%
5 Year Change112.98%
Change since IPO-79.35%

Recent News & Updates

Recent updates

Are Investors Undervaluing NIOX Group Plc (LON:NIOX) By 28%?

May 17
Are Investors Undervaluing NIOX Group Plc (LON:NIOX) By 28%?

We Think Shareholders Should Be Aware Of Some Factors Beyond NIOX Group's (LON:NIOX) Profit

Apr 03
We Think Shareholders Should Be Aware Of Some Factors Beyond NIOX Group's (LON:NIOX) Profit

We're Interested To See How Circassia Group (LON:CIR) Uses Its Cash Hoard To Grow

Jan 05
We're Interested To See How Circassia Group (LON:CIR) Uses Its Cash Hoard To Grow

Here's What Circassia Group Plc's (LON:CIR) Shareholder Ownership Structure Looks Like

Mar 13
Here's What Circassia Group Plc's (LON:CIR) Shareholder Ownership Structure Looks Like

Have Insiders Been Buying Circassia Group Plc (LON:CIR) Shares This Year?

Feb 04
Have Insiders Been Buying Circassia Group Plc (LON:CIR) Shares This Year?

Shareholder Returns

NIOXGB BiotechsGB Market
7D0%0.2%2.3%
1Y37.6%-27.3%2.7%

Return vs Industry: NIOX exceeded the UK Biotechs industry which returned -27.3% over the past year.

Return vs Market: NIOX exceeded the UK Market which returned 2.7% over the past year.

Price Volatility

Is NIOX's price volatile compared to industry and market?
NIOX volatility
NIOX Average Weekly Movement5.3%
Biotechs Industry Average Movement7.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: NIOX has not had significant price volatility in the past 3 months.

Volatility Over Time: NIOX's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200692n/ahttps://investors.niox.com

NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.

NIOX Group Plc Fundamentals Summary

How do NIOX Group's earnings and revenue compare to its market cap?
NIOX fundamental statistics
Market capUK£270.51m
Earnings (TTM)UK£9.50m
Revenue (TTM)UK£36.80m

28.5x

P/E Ratio

7.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NIOX income statement (TTM)
RevenueUK£36.80m
Cost of RevenueUK£10.30m
Gross ProfitUK£26.50m
Other ExpensesUK£17.00m
EarningsUK£9.50m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.022
Gross Margin72.01%
Net Profit Margin25.82%
Debt/Equity Ratio0%

How did NIOX perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.